Biomarkers in sepsis
暂无分享,去创建一个
[1] F. Massin,et al. Combination biomarkers to diagnose sepsis in the critically ill patient. , 2012, American journal of respiratory and critical care medicine.
[2] Jürgen Popp,et al. Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis , 2012, PLoS medicine.
[3] C. Natanson,et al. Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia , 2012, Intensive Care Medicine.
[4] D. Maslove,et al. Identification of sepsis subtypes in critically ill adults using gene expression profiling , 2012, Critical Care.
[5] D. Ledoux,et al. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients* , 2012, Critical care medicine.
[6] O. Tasaki,et al. Prognostic impact of fecal pH in critically ill patients , 2012, Critical Care.
[7] I. Guessous,et al. Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management , 2012, Critical Care.
[8] Taka-aki Nakada,et al. Normal-Range Blood Lactate Concentration in Septic Shock Is Prognostic and Predictive , 2012, Shock.
[9] Andrew Rhodes,et al. Drotrecogin alfa (activated) in adults with septic shock. , 2012, The New England journal of medicine.
[10] Fei Wang,et al. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis , 2012, Critical Care.
[11] C. Sprung,et al. Diastolic dysfunction and mortality in severe sepsis and septic shock. , 2012, European heart journal.
[12] J. Ge,et al. Relationship between thyroid function and ICU mortality: a prospective observation study , 2012, Critical Care.
[13] Biologic drugs set to top 2012 sales , 2012, Nature Medicine.
[14] Derek C Angus,et al. The search for effective therapy for sepsis: back to the drawing board? , 2011, JAMA.
[15] B. Nadjm,et al. Point-of-care measurement of blood lactate in children admitted with febrile illness to an African District Hospital. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] P. L. Petersen,et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial* , 2011, Critical care medicine.
[17] R. Agarwal,et al. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] J. Kellum,et al. Urinary biomarkers and renal recovery in critically ill patients with renal support. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[19] Benjamin Tang,et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis , 2011, Critical care.
[20] Alison Fox-Robichaud,et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis* , 2011, Critical care medicine.
[21] J. Vincent,et al. Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated) , 2010, Critical care.
[22] J. Weitz,et al. Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock. , 2010, The Journal of surgical research.
[23] B. Mougin,et al. EARLY ASSESSMENT OF LEUKOCYTE ALTERATIONS AT DIAGNOSIS OF SEPTIC SHOCK , 2010, Shock.
[24] M. Singer,et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. , 2010, American journal of respiratory and critical care medicine.
[25] Yanping Wang,et al. Troponin-I as a prognosticator of mortality in severe sepsis patients. , 2010, Journal of critical care.
[26] C. Sprung,et al. Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock , 2009, Intensive Care Medicine.
[27] J. Granger,et al. Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis* , 2009, Critical care medicine.
[28] Munish Goyal,et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis , 2009, Critical care medicine.
[29] M. J. Pearce,et al. Presymptomatic Prediction of Sepsis in Intensive Care Unit Patients , 2008, Clinical and Vaccine Immunology.
[30] M. Matthay,et al. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury , 2008, Critical care.
[31] D. Hoyer,et al. Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome* , 2008, Critical care medicine.
[32] Brian H Cuthbertson,et al. Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.
[33] John A Kellum,et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. , 2007, Archives of internal medicine.
[34] T. Holland-Letz,et al. Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study , 2007, Critical care.
[35] K. Larsen,et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study , 2007, Critical care.
[36] Anthony S McLean,et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.
[37] F. Di Maggio,et al. BIOMARKERS OF ACUTE RENAL INJURY AND RENAL FAILURE , 2006, Shock.
[38] G. Bernard,et al. Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome , 2006, Critical care.
[39] P. Collinson,et al. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients , 2006, Critical care.
[40] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[41] John Land,et al. Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.
[42] D. Annane,et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.
[43] M. Jiménez,et al. Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. , 1999, The Journal of infectious diseases.
[44] C. Sprung,et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.
[45] Jonathan Cohen,et al. A prospective study of fever in the intensive care unit , 1999, Intensive Care Medicine.
[46] C. Hinds,et al. Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. , 1997, Critical care medicine.
[47] K. Asadullah,et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.
[48] J E Parrillo,et al. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. , 1987, Critical care medicine.
[49] F. Massin,et al. Combination biomarkers to diagnose sepsis in the critically ill patient. , 2012, American journal of respiratory and critical care medicine.
[50] Fei Wang,et al. Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis , 2012, Critical Care.
[51] Jürgen Popp,et al. Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis , 2012, PLoS medicine.
[52] C. Natanson,et al. Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia , 2012, Intensive Care Medicine.
[53] D. Maslove,et al. Identification of sepsis subtypes in critically ill adults using gene expression profiling , 2012, Critical Care.
[54] D. Ledoux,et al. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients* , 2012, Critical care medicine.
[55] O. Tasaki,et al. Prognostic impact of fecal pH in critically ill patients , 2012, Critical Care.
[56] I. Guessous,et al. Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management , 2012, Critical Care.
[57] Taka-aki Nakada,et al. Normal-Range Blood Lactate Concentration in Septic Shock Is Prognostic and Predictive , 2012, Shock.
[58] Andrew Rhodes,et al. Drotrecogin alfa (activated) in adults with septic shock. , 2012, The New England journal of medicine.
[59] Fei Wang,et al. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis , 2012, Critical Care.
[60] Melinda Wenner Moyer,et al. Targeting hypoxia brings breath of fresh air to cancer therapy , 2012, Nature Medicine.
[61] C. Sprung,et al. Diastolic dysfunction and mortality in severe sepsis and septic shock. , 2012, European heart journal.
[62] J. Ge,et al. Relationship between thyroid function and ICU mortality: a prospective observation study , 2012, Critical Care.
[63] Biologic drugs set to top 2012 sales , 2012, Nature Medicine.
[64] Derek C Angus,et al. The search for effective therapy for sepsis: back to the drawing board? , 2011, JAMA.
[65] B. Nadjm,et al. Point-of-care measurement of blood lactate in children admitted with febrile illness to an African District Hospital. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[66] P. L. Petersen,et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial* , 2011, Critical care medicine.
[67] R. Agarwal,et al. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[68] J. Kellum,et al. Urinary biomarkers and renal recovery in critically ill patients with renal support. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[69] Benjamin Tang,et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis , 2011, Critical care.
[70] Alison Fox-Robichaud,et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis* , 2011, Critical care medicine.
[71] J. Vincent,et al. Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated) , 2010, Critical care.
[72] J. Weitz,et al. Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock. , 2010, The Journal of surgical research.
[73] B. Mougin,et al. EARLY ASSESSMENT OF LEUKOCYTE ALTERATIONS AT DIAGNOSIS OF SEPTIC SHOCK , 2010, Shock.
[74] M. Singer,et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. , 2010, American journal of respiratory and critical care medicine.
[75] Yanping Wang,et al. Troponin-I as a prognosticator of mortality in severe sepsis patients. , 2010, Journal of critical care.
[76] T. Baumann,et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. , 2009, American journal of respiratory and critical care medicine.
[77] C. Sprung,et al. Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock , 2009, Intensive Care Medicine.
[78] J. Marshall,et al. Biomarkers of sepsis , 2009, Critical care medicine.
[79] J. Granger,et al. Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis* , 2009, Critical care medicine.
[80] Munish Goyal,et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis , 2009, Critical care medicine.
[81] M. J. Pearce,et al. Presymptomatic Prediction of Sepsis in Intensive Care Unit Patients , 2008, Clinical and Vaccine Immunology.
[82] M. Matthay,et al. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury , 2008, Critical care.
[83] D. Hoyer,et al. Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome* , 2008, Critical care medicine.
[84] Brian H Cuthbertson,et al. Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.
[85] L. Trinquart,et al. Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure* , 2007, Critical care medicine.
[86] John A Kellum,et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. , 2007, Archives of internal medicine.
[87] T. Holland-Letz,et al. Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study , 2007, Critical care.
[88] K. Larsen,et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study , 2007, Critical care.
[89] Anthony S McLean,et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.
[90] F. Di Maggio,et al. BIOMARKERS OF ACUTE RENAL INJURY AND RENAL FAILURE , 2006, Shock.
[91] J. Schiettecatte,et al. Elevated serum levels of S-100&bgr; protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock* , 2006 .
[92] G. Bernard,et al. Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome , 2006, Critical care.
[93] P. Collinson,et al. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients , 2006, Critical care.
[94] J. Schiettecatte,et al. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. , 2006, Critical care medicine.
[95] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[96] John Land,et al. Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.
[97] D. Annane,et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.
[98] M. Jiménez,et al. Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. , 1999, The Journal of infectious diseases.
[99] C. Sprung,et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.
[100] Jonathan Cohen,et al. A prospective study of fever in the intensive care unit , 1999, Intensive Care Medicine.
[101] C. Hinds,et al. Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. , 1997, Critical care medicine.
[102] K. Asadullah,et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.
[103] J E Parrillo,et al. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. , 1987, Critical care medicine.